Titre : Tabac pour pipe à eau

Tabac pour pipe à eau : Questions médicales fréquentes

Termes MeSH sélectionnés :

Economic Development
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tabac pour pipe à eau : Questions médicales les plus fréquentes", "headline": "Tabac pour pipe à eau : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tabac pour pipe à eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-20", "dateModified": "2025-02-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tabac pour pipe à eau" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Produits du tabac", "url": "https://questionsmedicales.fr/mesh/D062789", "about": { "@type": "MedicalCondition", "name": "Produits du tabac", "code": { "@type": "MedicalCode", "code": "D062789", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767.844" } } }, "about": { "@type": "MedicalCondition", "name": "Tabac pour pipe à eau", "alternateName": "Tobacco, Waterpipe", "code": { "@type": "MedicalCode", "code": "D000073846", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Omar F Khabour", "url": "https://questionsmedicales.fr/author/Omar%20F%20Khabour", "affiliation": { "@type": "Organization", "name": "Faculty of Applied Medical Sciences, Department of Laboratory Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan." } }, { "@type": "Person", "name": "Karem H Alzoubi", "url": "https://questionsmedicales.fr/author/Karem%20H%20Alzoubi", "affiliation": { "@type": "Organization", "name": "Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan." } }, { "@type": "Person", "name": "Erin L Sutfin", "url": "https://questionsmedicales.fr/author/Erin%20L%20Sutfin", "affiliation": { "@type": "Organization", "name": "Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA esutfin@wakehealth.edu." } }, { "@type": "Person", "name": "Jennifer Cornacchione Ross", "url": "https://questionsmedicales.fr/author/Jennifer%20Cornacchione%20Ross", "affiliation": { "@type": "Organization", "name": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA." } }, { "@type": "Person", "name": "Thomas Eissenberg", "url": "https://questionsmedicales.fr/author/Thomas%20Eissenberg", "affiliation": { "@type": "Organization", "name": "Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States of America." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Estimating the economic impact of complications after open tibial fracture: A secondary analysis of the pilot Gentamicin Open Tibia trial (pGO-Tibia).", "datePublished": "2024-01-19", "url": "https://questionsmedicales.fr/article/38249318", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/OI9.0000000000000290" } }, { "@type": "ScholarlyArticle", "name": "Clinical and economic burden of anxiety/depression among older adult COPD patients: evidence from the COPD-AD China Registry study.", "datePublished": "2024-01-08", "url": "https://questionsmedicales.fr/article/38260779", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpsyt.2023.1221767" } }, { "@type": "ScholarlyArticle", "name": "Responsibility-sharing and compensation scheme of transboundary water pollution embodied in China's inter-provincial trade: a perspective from economic value capturing.", "datePublished": "2024-01-05", "url": "https://questionsmedicales.fr/article/38180659", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-023-31708-w" } }, { "@type": "ScholarlyArticle", "name": "Strengthening social capital in the Sri Lankan population: A qualitative exploration of factors driving the mothers' support groups initiative during economic crisis.", "datePublished": "2023-12-16", "url": "https://questionsmedicales.fr/article/38235012", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.34172/hpp.2023.35" } }, { "@type": "ScholarlyArticle", "name": "An Atom-Economic Method for 1,2,3-Triazole Derivatives via Oxidative [3 + 2] Cycloaddition Harnessing the Power of Electrochemical Oxidation and Click Chemistry.", "datePublished": "2023-11-04", "url": "https://questionsmedicales.fr/article/37924324", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.joc.3c01836" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Dispositifs pour fumer", "item": "https://questionsmedicales.fr/mesh/D000074602" }, { "@type": "ListItem", "position": 5, "name": "Produits du tabac", "item": "https://questionsmedicales.fr/mesh/D062789" }, { "@type": "ListItem", "position": 6, "name": "Tabac pour pipe à eau", "item": "https://questionsmedicales.fr/mesh/D000073846" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tabac pour pipe à eau - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tabac pour pipe à eau", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tabac pour pipe à eau", "description": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?\nQuels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Economic+Development&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tabac pour pipe à eau", "description": "Quels sont les symptômes d'une consommation excessive ?\nComment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Economic+Development&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tabac pour pipe à eau", "description": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?\nQuelles campagnes sont efficaces contre le tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Economic+Development&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tabac pour pipe à eau", "description": "Quels traitements existent pour arrêter le tabac à pipe à eau ?\nLes médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Economic+Development&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tabac pour pipe à eau", "description": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?\nLe tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Economic+Development&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tabac pour pipe à eau", "description": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?\nLes femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?", "url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Economic+Development&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une consommation excessive ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires." } }, { "@type": "Question", "name": "Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il peut causer des maladies des gencives, des caries et des taches sur les dents." } }, { "@type": "Question", "name": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation sur les risques et la promotion d'activités alternatives sont essentielles." } }, { "@type": "Question", "name": "Quelles campagnes sont efficaces contre le tabac à pipe à eau ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs." } }, { "@type": "Question", "name": "Quels traitements existent pour arrêter le tabac à pipe à eau ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les thérapies comportementales et les substituts nicotiniques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer." } }, { "@type": "Question", "name": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon." } }, { "@type": "Question", "name": "Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs." } }, { "@type": "Question", "name": "Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse." } } ] } ] }

Sources (10000 au total)

Estimating the economic impact of complications after open tibial fracture: A secondary analysis of the pilot Gentamicin Open Tibia trial (pGO-Tibia).

To estimate the indirect economic impact of tibial fractures and their associated adverse events (AEs) in Tanzania.... A secondary analysis of the pilot Gentamicin Open (pGO)-Tibia randomized control trial estimating the indirect economic impact of suffering an AE, defined as a fracture-related infection (FRI) and/or ... The pGO-Tibia trial was conducted from November 2019 to August 2021 at the Muhimbili Orthopaedic Institute in Dar es Salaam, Tanzania.... One hundred adults with open tibial shaft fractures participated in this study.... Work hours were compared between AE groups. Cost data were analyzed using a weighted-average hourly wage and converted into purchasing power parity-adjusted USD.... Indirect economic impact was analyzed from the perspective of return to work (RTW), lost productivity, and other indirect economic and household costs. RTW was analyzed using a survival analysis.... Half of patients returned to work at 1-year follow-up, with those experiencing an AE having a significantly lower rate of RTW. Lost productivity was nearly double for those experiencing an AE. There w... This study identified serious economic burden after tibial fractures, with significant differences in total indirect cost between those with and without an AE.... II....

Clinical and economic burden of anxiety/depression among older adult COPD patients: evidence from the COPD-AD China Registry study.

Anxiety and depression are common in patients with chronic obstructive pulmonary disease (COPD), especially older adult patients. This can complicate the disease progression and lead to increased clin... We screened 579 patients aged over 60 years and diagnosed with COPD via a lung function test following the 2017 Global Initiative Chronic Obstructive Lung Disease (GOLD) guidelines. Anxiety and depres... Compared with COPD-only patients, COPD patients complicated with anxiety and/or depression had increased clinical burden, including higher COPD-related outpatient visits, COPD-related hospitalizations... Older adult COPD patients with anxiety or depression had significantly higher clinical and economic burdens than patients without these comorbidities. These findings deserve further exploration and ma...

Strengthening social capital in the Sri Lankan population: A qualitative exploration of factors driving the mothers' support groups initiative during economic crisis.

Social capital is a concept that has been identified to improve health outcomes in many populations. Due to COVID-19 and many other factors, Sri Lanka faced a massive economic crisis that affected the... We conducted a case study on the activities undertaken by mothers' support groups in view of how they focused on social capital. We selected all activities presented by districts that improved social ... Six major themes were identified (that social capital had been strengthened to promote nutrition): awareness creation of nutrition, home gardening promotion, promoting livestock farming, minimizing fo... Social capital can improve nutritional status during crises. Activities that can be used to achieve this vary from simple awareness creation among communities to more advanced psychosocial health prom...

Povidone-iodine intra-abdominal irrigation versus no irrigation in pediatric perforated appendicitis: A secondary economic analysis of a Bayesian randomized controlled trial.

A pilot randomized controlled trial (RCT) conducted in children (2-17 ​y) with perforated appendicitis demonstrated an 89% probability of reduced intra-abdominal abscess (IAA) rate with povidone-iodin... We conducted a retrospective economic analysis of a pilot RCT. Hospital costs, inflated to 2019 U.S. dollars, were obtained for index admissions and 30-day emergency visits and readmissions. Cost diff... We observed a 95% Bayesian probability that PVI reduced 30-day mean total hospital costs ($16,555 [PVI] versus $18,509 [NI]; Bayesian cost ratio: 0.90, 95% CrI, 0.78-1.03). The mean absolute differenc... PVI likely reduced the IAA rate and 30-day hospital costs, suggesting the intervention is both clinically superior and cost saving....

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece.

Higher valency pneumococcal conjugate vaccines (PCVs) are expected to improve protection against pneumococcal disease through coverage of additional serotypes. The aim of the present study was to eval... A published Markov model was adapted to simulate lifetime risk of clinical and economic outcomes from the public payer's perspective. The model population was stratified based on age and risk profile ... Over the modeled time horizon, vaccination with PCV20 compared to PCV15 alone or PCV15 followed by PPV23 prevents an additional 747 and 646 cases of IPD, 10,334 and 10,342 cases of NBP and 468 and 455... PCV20 is estimated to improve public health by averting additional pneumococcal disease cases and deaths relative to PCV15 alone or followed by PPV23, and therefore translates to cost-savings for the ...

Factors contributing to socio-economic inequality in utilization of caesarean section delivery among women in Indonesia: Evidence from Demographic and Health Survey.

Most of the existing literature in developing countries focused on either the rising trend of CS or its determinants. There is a paucity of population-based studies on existing socioeconomic inequalit... The study utilized nationally representative cross-sectional data from the Indonesia Demographic and Health Survey (IDHS), 2017. We conducted multivariable logistic regression to find the factors asso... About 17% of women in Indonesia delivered babies through CS. A concentration index of 0.31 in CS delivery rate showed a higher CS delivery rate among women belonging to rich households. About 44.7% of... The study highlighted the higher CS delivery rates among women from higher socioeconomic groups and thus, it is important to frame policies after identifying the population subgroups with potential un...

Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial.

THALES demonstrated that ticagrelor plus aspirin reduced the risk of stroke or death but increased bleeding versus aspirin during the 30 days following a mild-to-moderate acute non-cardioembolic ischa... Cost-effectiveness was evaluated using a decision tree and Markov model with a short-term and long-term (30-year) horizon. Stroke, mortality, bleeding and EuroQol-5 Dimension (EQ-5D) data from THALES ... One-month treatment with ticagrelor plus aspirin resulted in 12 fewer strokes, 4 additional major bleeds and cost savings of €95 000 per 1000 patients versus aspirin from a Swedish healthcare perspect... One month of treatment with ticagrelor plus aspirin is likely to improve outcomes and reduce costs versus aspirin in mild-to-moderate AIS or high-risk TIA.... NCT03354429....